Health Highlights: Oct. 1, 2021
Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more
1 in 4 parents say their kids have been quarantined since school started: Still, roughly two-thirds of parents think schools are taking appropriate measures to contain the spread of COVID-19. Read more
Has the pandemic made the opioid epidemic worse? In interviews with HealthDay Now, experts say that overdoses soared, but the rise of telehealth also helped many get vital treatments.Read more
A silver lining to the pandemic: less vaping among teens. New statistics show a 40% drop in use, as teens had to stay home more during lockdowns and closures. Read more
New data shows police killings underreported: And Black Americans were 3.5 times more likely to die from police violence than white Americans, the study found. Read more
Copyright ©2022 HealthDay. All rights reserved.